Actos® Side Effects

In 2010, the FDA issued a warning that the long-term use of Actos, an oral diabetes drug generically known as pioglitazone, may be linked to bladder cancer. In 2011, an interim analysis of a ten-year observational study found that there may be a 40 percent increased risk of bladder cancer among those who have taken Actos for more than one year.

Actos, as well as the pioglitazone-containing drug Duetact, are prescribed to help control type 2 diabetes in patients whose conditions are not adequately controlled by diet and exercise alone.

If you’ve taken Actos® or Duetact® for more than one year to help with your type 2 diabetes and have since developed bladder cancer, we can help you understand your options and seek justice against those responsible.

April 7, 2014

Case Update:  $9 Billion Actos Decision on Eli Lilly and Takeda Pharmaceuticals

On Monday, April 7, a federal court jury in Louisiana decided that Takeda Pharmaceuticals and Eli Lilly hid the risks of bladder cancer from the diabetes drug, Actos. Takeda was ordered to pay $6 billion and Eli Lilly was ordered to pay $3 billion. Read more

Contact a Medical Attorney

If you or someone you know took Actos or Duetact and developed bladder cancer, contact our medical team to learn if you may have a case.

Actos and Bladder Cancer

Actos is manufactured by Takeda Pharmaceutical Company Limited and co-marketed in the United States by Eli Lilly and Company. It was originally approved by the FDA in 1999 to improve the control of blood sugar in adults with type 2 diabetes. The drug belongs to a class of drugs known as thiazolidinediones; medications intended to lower blood glucose levels and increase the body's sensitivity to insulin.

Some countries have taken a more aggressive approach to limiting the sale and prescription of Actos. Following the release of a French study showing a possible increased risk of bladder cancer with Actos use, both France and Germany suspended sales and prescriptions of the drug.

The FDA states it will continue to monitor data from the 10-year study, conduct a comprehensive review of the results from the French study and provide updates when more information becomes available.

Our Commitment to You

When a drug you’re taking to improve one condition has unexpected harmful or even deadly side effects, it is your right to pursue justice and to seek to hold the manufacturer responsible. If you believe that you have a claim, contact us via email or call 1.800.768.4026.

See more Medical Drug litigation >